The human T-cell-or lymphocyte-specific gene, kck, encodes a tyrosine kinase and is a member of the src family. In this report we demonstrate that there are two classes of human kck transcripts (types I and II), containing different 5'-untranslated regions, which are expressed from two distinct promoters. No apparent sequence similarity was observed between the 5'-flanking regions of the two promoters. The The T-cell-or lymphocyte-specific tyrosine kinase Ick is a recently described member of the src gene family (3, 5, 9, 10, 15, 18, 25) . The product of the Ick gene, p56lck, is found mainly associated with T lymphocytes and is expressed at elevated levels in certain T-cell leukemic and lymphoma cell lines (10, 11, 18, 22, 25) . This increased level of lck has led to its isolation in both murine and human T-lymphoma cells (10, 18). The human lck gene is also expressed in colon carcinoma and other nonlymphoid tumor cell lines (22). The expression of Ick message or protein (or both) is developmentally regulated. For example, T-lymphoma cell lines arrested at early stages of differentiation have low levels of lck transcripts; lck expression increases progressively to high levels in cells at developmental stages corresponding to those of mature thymocytes before decreasing to intermediate levels in peripheral blood T lymphocytes (11). In addition, the immature T-cell leukemia cell line, P30/OKUBO, can be induced to express high levels of Ick transcripts by treatment with tetradecanoylphorbol acetate (TPA) (11). Furthermore, the levels of Ick transcripts can be transiently down regulated in peripheral blood T lymphocytes induced to proliferate by treatment with TPA and phytohemagglutinin (PHA) (16).
. However, neither the sequence of the 5' (or upstream) promoter, from which type II lck transcripts initiate, nor the expression of the individual type I and II transcripts during T-cell development or activation has been determined. We report here the isolation and sequence of the two human lck promoter regions and the identification of the RNA start sites for the type I and II transcripts. Further, we show that (at least) the upstream lck promoter is differentially used during T-cell development and activation in vitro.
MATERIALS AND METHODS
Cells. Human T-cell leukemia (Jurkat, HSB-2, and P30/ OKUBO) and colon carcinoma (COLO 201, COLO 205, COLO 320HSR, HT 29, and SW 948) cell lines were cultured in RPMI 1640 medium containing 10% fetal calf serum. Peripheral blood mononuclear cells were obtained from normal adult donors by Ficoll-Paque (Pharmacia, Inc., Piscataway, N.J.) centrifugation, and T lymphocytes were isolated by E rosetting with sheep erythrocytes. Human HeLa cells were cultured in alpha medium containing 10% fetal calf serum.
Chemicals. TPA (P-L Biochemicals, Inc., Milwaukee, Wis.), PHA (Wellcome Foundation, Ltd., Beckenham, England), and cyclosporin A (CsA) (Sandoz Canada, Inc., Dorval, Quebec, Canada) were used at final concentrations of 32 nM, 160 ,ug/ml, and 1 ,ug/ml, respectively, in RPMI 1640 medium containing 10% fetal calf serum.
Genomic library and library screening. A 2-kilobase (kb) EcoRI fragment containing the entire lck coding sequence and a 0.3-kb EcoRI-BglII fragment containing the 5' UTR from the human lck cDNA clone YT16 (10) were used as probes for screening the genomic library of Maniatis et al. (14) . Six clones were isolated; one hybridized to a synthetic oligonucleotide probe (30-mer) that spans nucleotides 36 to 7 upstream of the starting ATG codon in YT16 (10) .
DNA sequencing. Relevant DNA fragments were isolated 2174 TAKADERA ET AL.
from the bacterial X phage clones, digested with appropriate restriction enzymes, and subcloned into M13mp8 and M13mp9 for sequence analysis by using the Sanger dideoxychain termination technique (19) . Northern (RNA) blot analysis. Total cellular RNA was extracted from cells by homogenization in the presence of guanidine hydrochloride. Glyoxalated RNA (10 ,ug) was electrophoresed through a 1% agarose gel in 10 mM sodium phosphate buffer (pH 7.0), transferred to Gene Screen Plus (Dupont, NEN Research Products, Boston, Mass.), and then hybridized with the full-length human Ick (YT16) and interleukin-2 (IL-2) nick-translated probes as described previously (11) . The quality and quantity of RNA isolated from the various cell sources were verified by probing the Northern blots with a hamster a-tubulin probe.
Si nuclease mapping. For the downstream lck promoter, a 321-base-pair (bp) FokI-ClaI fragment 32P-labeled at the ClaI site and complementary to positions -60 to +261 (see Fig.  2A ) was used as an S1 probe. For the upstream promoter, a 197-bp HindIII-XmaI fragment 32P-labeled at the XmaI site and complementary to positions -100 to +97 (Fig. 2B ) was used as an Si probe. Hybridization of 20 to 30 ,ug of total cellular RNA to 10,000 cpm of probe was carried out as described previously (26) , except that the hybridization temperature was 50°C. Samples were treated with 150 U of S1 nuclease (Boehringer Mannheim Biochemicals, Indianapolis, Ind.) at 20°C for 2 h. 32P-labeled, S1 nuclease-protected products were processed as described previously (13) and then fractionated through 6% polyacrylamide-8 M urea sequencing gels. Autoradiography of the dried gels was performed with XAR film (Eastman Kodak Co., Rochester, N.Y.) and an intensifying screen (Cronex Lightning-Plus; E. I. du Pont de Nemours & Co., Inc., Wilmington, Del.) at -700C.
Primer extension analysis. A 30-mer 5'-32P-end-labeled (25 ,000 cpm per reaction) oligonucleotide complementary to codons 7 to 16 of the lck coding region (see Fig. 2A ) was hybridized to 20 to 30 ,u g of total cellular RNA at 37°C for 14 to 16 h and analyzed by primer extension exactly as described previously (7) . Electrophoresis and autoradiography were performed as described above for S1 nuclease mapping.
RESULTS
Restriction map of the human kck gene. To characterize the sequences involved in regulating the expression of the human lck gene, we first isolated its 5'-flanking regions by screening the Maniatis human genomic library (14) , using the human lck cDNA (YT16 [10] ) as the probe. A phage clones containing lck sequences were isolated, and restriction maps of the inserts were determined by using the enzymes EcoRI, HindIII, and PstI. Figure 1 shows the restriction maps of two clones, X1T (18.3 kb) and XSG (15.3 kb) , which hybridized to the YT16 probe. This probe hybridized with an 8-kb EcoRI subfragment of X1T (p16G1T2N), and the 9.3 (p5Gl)-and 4.8-kb EcoRI fragments of XSG. In addition, a synthetic oligonucleotide probe (30-mer) representing the 5' UTR of YT16 ( Fig. 2A) hybridized to X1T, whereas the coding region of YT16 and a different 5' UTR (see below) are contained within XSG. A distance of more than 9 kb separates these two 5' UTRs of the human lck gene (Fig. 1) .
Sequences of the two human kk promoter regions. Previous studies indicate that two lck transcripts, with different 5' UTRs, are expressed in murine T cells (2, 8, 24 ning the two human lck 5' UTRs (Fig. 2) . Figure 2A shows the sequence of the 0.7-kb PstI fragment and part of the 6-kb PstI fragment of p5G1 ( Fig. 1 (4, 20) sites are located at positions +204 and +315, respectively. Figure 2B shows the sequence of the 1-kb EcoRI-PstI fragment of p16G1T2N ( Fig. 1) (4, 7, 27) . This search also failed to detect any strong homologies to typical enhancer motifs in either of the two Ick promoters. However, Adler et al. (2) noticed that a sequence in the mouse type I Ick promoter between positions -64 and -57 matches the immunoglobulin heavy-chain enhancer consensus sequence. This octanucleotide sequence (CCAGGTGG) is also present in the human type I lck promoter between positions -47 and -40 (Fig. 2A) ; this region has been shown to be highly conserved between human and mouse cells (8) .
Transcription start sites of the human lkk gene. To determine the RNA start sites of the lck gene, we used the methods of S1 nuclease and primer extension mapping. We analyzed total cellular RNA from a human T-cell leukemia cell line, Jurkat, which has been shown to constitutively express abundant amounts of lck transcripts (11) . Total cellular RNA from human HeLa S-3 cervical carcinoma epithelial cells served as a negative control. We first used a 321-bp FokI-ClaI fragment ( Fig. 2A) labeled at the ClaI site as an S1 probe to detect type I lck transcripts initiated from the downstream promoter. Two S1 nuclease-protected fragments of approximately 261 and 241 bases in length and corresponding to start sites Ia and lb ( Fig. 2A) , respectively, YT16 from positions +261 to +202 (Fig. 2A) . The other -61 bands detected in this Si nuclease analysis were visible in both the Jurkat and HeLa cell lines (Fig. 3A) .
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We next used a 197-bp HindIII-XmaI fragment (Fig. 2B (Fig. 2B) . The apparent discrepancy in sizes of bands generated by primer extension as compared with Si nuclease mapping was due to differences in the positions of the 5' ends of the primer and the Si +120 probes (Fig. 2) . Thus, the primer extension products were 4 bases smaller or 62 bases larger than the corresponding Si niiclease-protected fragments for the type I or II Ick tranproscripts, respectively ( Fig. 3 and 4) . The relative intensities of (A) the bands generated for each of the identifiable RNA start pSG1 sites were roughly similar in the two assay systems (compare ently the Jurkat lanes in Fig. 4 with those in Fig. 3 ). The primer de is extension product of 109 bases in length, which was ob-98-bp served only in the T-cell lanes (Fig. 4) Fig. 2 as the primer. nuclease mapping identified several type I start sites (Fig. 3C  and 2B [V]) for which no corresponding primer extension products were detected (Fig. 4) .
Modulation of Ick transcripts during T-cell development. Previously we had shown that expression of Ick is developmentally regulated during T-cell maturation. Northern blot analysis of total cellular RNA with the full-length human Ick cDNA YT16 as the probe revealed that immature thymocytes and mature T cells express lower levels of Ick than do more mature thymocytes (11) . In addition, Ick expression was shown to be inducible by phorbol esters, as exposure of the immature T-cell line, P30/OKUBO, to TPA for 24 h resulted in a marked increase in the levels of lck transcripts (11) . It was of interest, therefore, to determine whether the modulation of Ick expression during the development of T cells may involve the regulation of expression of Ick transcripts that initiate from either a particular set of start sites or one of the two Ick promoters.
The Si nuclease-protected fragments of 261, 241, and 60 bases in length, which correspond to start sites Ta and Tb and spliced type II transcripts, respectively, were detected in RNA from HSB-2 cells, whereas only the spliced type II transcripts were present at detectable levels in untreated P30/OKUBO cells (Fig. 5) . As expected from our previous work (11), primer extension and Si nuclease mapping experiments revealed higher levels of Ick transcripts of T-cell leukemia cells corresponding to mature thymocytes (Jurkat and HSB-2) than in immature thymocytes (P30/OKUBO) or peripheral blood T lymphocytes (Fig. 4 (Fig.  2) , and primer extension was performed as described in Materials and Methods. P30/OKUBO cells and peripheral blood T lymphocytes (Peri Blood T) were treated with TPA alone or TPA plus PHA, respectively, at concentrations described in Materials and Methods, for 0 to 24 h as indicated above the lanes. The approximate sizes of the primer extension products and the start sites that each of the bands represents (Fig. 2) are indicated. A Northern blot analysis of the RNA using the hamster a-tubulin probe (see Materials and Methods) indicated that the sample prepared from P30/OKUBO cells treated with TPA for 4 h was underrepresented (not shown). Sanger sequencing ladders were as described for Fig. 3 .
HSB-2 cells was due to an increase in steady-state levels of both type I and II transcripts, suggesting an increased activity of the two lck promoters. We also observed that type TI transcripts are found in consistently greater abundance than type I transcripts, suggesting that the upstream promoter is more active than the downstream promoter. It should be noted that although the type I and II Ick mRNAs were dissimilar only in their 5' UTRs, it is possible that the steady-state levels of the type I and II transcripts do not accurately reflect the transcription rates from the downstream and upstream promoters, respectively.
Confirming our previous results (11), Fig. 6A shows that TPA induced the expression of Ick at the steady-state RNA level and that this increase was detected within 4 h after addition of TPA. Si nuclease and primer extension mapping experiments were then used to estimate the frequency of utilization of specific start sites in the two Ick promoters in TPA-treated P30/OKUBO cells. A steady increase in the intensities of the Si nuclease-protected fragment of 60 bases in length (Fig. 5 ) and the primer extension products of 159, 141, and 125 bases in length (Fig. 4) was observed upon exposure of the P30/OKUBO cells to TPA. A barely detectable Si nuclease-protected fragment of 261 bases in length was also observed with RNA from TPA-treated (but not from untreated) P30/OKUBO cells (Fig. 5) . However, bands corresponding to type I (Ta and Ib) or minor type II (IIa/TIb) transcripts were not detected by the primer extension analysis (Fig. 4) . Nevertheless, these results suggest that the induction of Ick expression in P30/OKUBO cells by TPA is mediated primarily by increases in the steady-state levels of type TI transcripts. Fig. 3 . Upon longer exposure of this autoradiogram (not shown), the presence of an S1 nuclease-protected fragment of 261 bases in length was more clearly visible, and the additional S1 nuclease-protected fragments present in RNA from HSB-2 cells were observed in RNA from HeLa cells.
Modulation of kck transcripts during T-cell activation. Recently, it has been reported that the level of Ick transcripts in peripheral blood T lymphocytes declines transiently between 4 and 8 h after addition of PHA and TPA, and this modulation of Ick expression closely correlates, in an inverse relationship, with the induction of lymphokine production (16) . To determine the relative lck promoter usage in human peripheral blood T lymphocytes activated by PHA and TPA, we attempted to quantitate the Ick transcripts initiating from both the upstream and downstream promoter start sites by primer extension. Figure 4 shows that the levels of the primer extension products corresponding to lck transcripts initiating from start sites TIc, Ild, and ITe coordinately declined 4 to 8 h after addition of PHA plus TPA and increased by 24 h. Type I and Ila/IIb Ick transcripts were not detected by this assay.
As CsA, an effective immunosuppressive agent, is known to inhibit the induction of interleukin-2 (IL-2) transcripts by PHA and TPA (6, 12) , we examined the effect of CsA on the PHA-plus-TPA-mediated down regulation of Ick transcripts. As expected from the work of Marth et al. (16) , treatment of peripheral blood T lymphocytes for 4 h with PHA and TPA resulted in a reduction of Ick transcripts that was coincident with the induction of IL-2 transcripts; this induction of IL-2 was indeed suppressed by cotreatment with CsA (Fig. 6B) . scripts mediated by PHA and TPA (Fig. 6B) . The lower steady-state levels of Ick transcripts in peripheral blood T lymphocytes activated by PHA and TPA were reflected by a general decrease in all of the type II Ick transcripts as determined by primer extension (data not shown).
Expression of kck transcripts in human colon carcinoma cell lines. In addition to its expression in T cells, the human Ick gene is also expressed at high levels in a subset of colon carcinoma cells and at moderate levels in a variety of other nonlymphoid tumor cells (22) . We performed primer extension mapping experiments with total cellular RNA from several human colon carcinoma cell lines. In cells that express Ick at high levels, such as COLO 201 and COLO 205 (22), we detected type I and II Ick transcripts in amounts similar to those observed in Jurkat T-cell leukemia cells (Fig.  7) . We detected low amounts of type II transcripts in SW 948 cells, and we were unable to detect any Ick transcripts in HT 29 cells (data not shown); both of these cell lines express Ick at very low levels (22) . We also detected Ick-specific primer extension products in COLO 320HSR cells; however, the start sites used were different from those used in T cells (data not shown).
DISCUSSION
We have determined the structure of the human Ick gene upstream and downstream promoter regions and mapped their transcription start sites. By S1 nuclease and primer extension mapping we have shown that, as in the mouse (2, 8, 24) , two classes of Ick transcripts are expressed in human T cells. In fact, at least two RNA start sites from the downstream promoter and five start sites from the upstream promoter can be detected. Transcripts initiating from the downstream and upstream promoters have been denoted type I and II Ick transcripts, respectively (2, 24) . The human type I Ick transcripts initiated 210 and 189 bp upstream of the ATG translation initiation codon. The murine Ick cDNA NT18 is derived from a transcript of this type (18) . The type II Ick transcripts initiated from a promoter located at least 9 kb from the downstream promoter in both human ( Fig. 1 ) and mouse (2) cells and created an alternative 5' UTR through splicing to 5 nucleotides 5' to the initiation ATG codon. The human Ick cDNA YT16 (10) and the murine lck cDNA pA2 (2) are derived from transcripts of this type.
The human type I Ick transcript which initiated at start site lb at position +21 ( Fig. 2A) corresponds to the major start site identified in the murine Ick downstream promoter (2, 8) . Interestingly, the major type I start site used in human T cells (Ia) has been described as a possible minor start site in the murine Ick downstream promoter (2) . Of potential importance is the observation that a 4-bp gap was inserted into the mouse sequence at the human type I transcript Ia start site (8) to align the sequences of the human and mouse Ick downstream promoters. It will be of interest to determine whether this difference in start site utilization is involved in regulating ick expression from the downstream promoter.
We analyzed the sequences of the human Ick upstream and downstream promoters by using the Sequence Analysis Software Package from the Genetics Computer Group at the University of Wisconsin. From this analysis, it appeared that the 5'-flanking regions of the two human Ick promoters are unrelated. Furthermore, we were unable to identify any consensus sequences for known eucaryotic cis-acting elements, such as the TATA box, which is responsible for the positioning of the mRNA start sites or level of transcription from a promoter (or both) (4), or for other regulatory elements usually located in the proximal 5'-flanking region of RNA polymerase II promoters (27) . It is possible that the lack of consensus TATA box sequences in both the upstream and downstream promoter regions is responsible for the multiple type I and II RNA start sites.
In the Moloney murine leukemia virus-induced murine thymoma cell line, LSTRA, Moloney murine leukemia virus has been inserted 969 bp 5' to the type I promoter start site (2, 8 (17) . It is noteworthy that in the 5' UTR of the normal murine lck downstream promoter, the presence of three AUG sequences upstream of the initiator AUG codon has been shown to reduce the efficiency of p56lck translation (17) . Two of these AUG sequences, at +78 and +148, are conserved in the human type I Ick transcripts. The former is in frame with the initiator AUG codon such that a peptide of 44 additional amino acids could be produced. The human type II lck transcripts also have two out-of-frame upstream AUG sequences, at +71 and +77, interrupted by a TGA termination codon. It will be of interest to determine whether these AUG sequences in the 5' UTR of the human lck type I and II mRNAs play a role in regulating p56Ick translation.
In the human T-cell lines tested (Jurkat, HSB-2, and P30/OKUBO) and in human peripheral blood T lymphocytes, type II lck transcripts were found in greater abundance than type I lck transcripts, suggesting that the upstreamlck promoter is more active than the downstream lck promoter. In agreement, it has been shown by Northern blot analysis with type I-and II-specific probes that type II lck transcripts are found in greater relative abundance in human thymus than in Jurkat cells (8) . In fact, we were unable to detect, by primer extension, type I lck transcripts in either P30/OKUBO cells or peripheral blood T lymphocytes. It will be necessary to use more-sensitive assays, such as RNase protection, to detectlck transcripts that initiate from either the type I or minor type II RNA start sites. In contrast with our findings, it has been reported recently that the relative usage of two lck promoters varies considerably in certain murine T-cell lines (24 proteins, which are expressed on the surface of functionally distinct populations of T cells, both bind to p56Ick (21) . Thus, the expression ofIck in colon carcinoma cells is intriguing in view of the observation that CD4, which is felt to represent the human immunodeficiency virus receptor on T helper cells, is also expressed in some colon carcinoma cells (1) .
Therefore, expression of Ick is likely to be central to the development of thymocytes or the activation of T cells or both and may be important in the progression of some nonlymphoid tumors as well. The elucidation of the molecular mechanisms regulating Ick transcription and translation will be beneficial towards a further understanding of the cellular role(s) of p561ck.
